Neoadjuvant strategies for advanced pancreatic neuroendocrine tumors: should combined chemotherapy and peptide receptor radionuclide therapy be the preferred regimen for maximizing outcome?
No abstract available
Source: Nuclear Medicine Communications - Category: Nuclear Medicine Tags: Letter to the Editor Source Type: research
More News: Brain | Chemotherapy | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Neurology | Nuclear Medicine | Pancreas